{"nct_id":"NCT06581406","title":"A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-12-17","start_date_type":"ACTUAL","primary_completion_date":"2030-01","primary_completion_date_type":"ESTIMATED","completion_date":"2031-10","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["REPL"]}